Company Profile

Trade Name KYORIN Pharmaceutical Co.,Ltd.
Business Manufacture and sales of prescription medicines
Head Office 6, Kanda Surugadai 4-Chome, Chiyoda-ku,
Tokyo 101-8311 Japan (Access Map)
Telephone 03-3525-4711
Foundation 1923
Establishment 1940
Outstanding Shares 74,268 thousand
Common Stock ¥ 4,317 million
Employees 1,687 (as of March 31, 2017)

Board of Directors

(As of June 23, 2017)

Representative Director, President and Chief Executive Officer Minoru Hogawa
Executive Director Masahiro Yamashita
Senior Managing Director Tomiharu Matsumoto
Senior Executive Director Yutaka Ogihara
Shigeru Ogihara
Executive Director Kazuhiro Marubayashi
Tomiya Sasahara
Kenji Akutsu
Corporate Auditor Seiyu Miyashita
Syuugo Tamaki
Senior Corporate Officer Masahide Sugibayashi
Kouji Murakami
Koichiro Hagihara
Corporate Officer Tetsuo Tatsumi
Katsuyoshi Fujii
Yasuyuki Shimokawa
Morio Yanagishima
Tokutaro Yasue
Toshiyuki Tamayama

Subsidiaries

ActivX Biosciences, Inc.

President Hugh Rosen
Capital US$1 (Percentage of ownership: 100%)
Head Office 11025 N. Torrey Pines Rd.
La Jolla, CA 92037, United States
Operations Discovery and evaluation of candidate compounds
URL http://www.activx.com/

Kyorin USA, Inc.

President Kazumi Taguchi
Capital US$500,000 (Percentage of ownership: 100%)
Head Office 500 Frank W.Burr Boulevard Teaneck,
New Jersey 07666, United States
Operations Research and analysis of other companies' technologies and collection of information concerning clinical trials

Kyorin Europe GmbH

Managing Director Takashi Kato
Capital €50,000 (Percentage of ownership: 100%)
Head Office Kaiserstrasse 8,60311
Frankfurt am Main, Germany
Operations Research and analysis of other companies' technologies and collection of information concerning clinical trials